Phase Ib study of SCT200 combined with paclitaxel or docetaxel in patients with recurrent or metastatic head and neck squamous cell carcinoma following platinum-based chemotherapy and PD-1 antibody.
Lin J, Qu S, Yang K, Zhang T, Bai Y, Wu J, Huang Y, Fang M, Liu X, Huang X, Chen N, Li Z, Li W, Zhang S, Zhang S, Hu G, Sun Y, Chen X, Liu Y, Jing S, Shen L, Chang Z, Xie L, Gai W, Zhou Q, Chen X, Yi J, Guo Y.
Lin J, et al. Among authors: huang y.
Cancer Lett. 2025 Jan 30:217513. doi: 10.1016/j.canlet.2025.217513. Online ahead of print.
Cancer Lett. 2025.
PMID: 39892704